2024 Q4 Form 10-Q Financial Statement

#000106299324019025 Filed on November 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit
Operating Expenses $115.2K
YoY Change 11.43%
Operating Profit -$115.2K
YoY Change 11.43%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $595.00
YoY Change -103.65%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$114.6K
YoY Change -4.24%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 60.86M shares 60.86M shares
Diluted Shares Outstanding 60.86M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $141.5K
YoY Change -85.54%
Cash & Equivalents $141.5K
Short-Term Investments $0.00
Other Short-Term Assets $54.71K
YoY Change 38.23%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $196.2K
YoY Change -80.73%
LONG-TERM ASSETS
Property, Plant & Equipment $332.5K
YoY Change 14.53%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $339.3K
YoY Change 7.14%
TOTAL ASSETS
Total Short-Term Assets $196.2K
Total Long-Term Assets $339.3K
Total Assets $535.6K
YoY Change -59.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $37.18K
YoY Change 12.77%
Accrued Expenses $143.7K
YoY Change 5.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.286M
YoY Change 2.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $81.25K
YoY Change -9.72%
Total Long-Term Liabilities $81.25K
YoY Change -9.72%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.286M
Total Long-Term Liabilities $81.25K
Total Liabilities $1.367M
YoY Change 1.79%
SHAREHOLDERS EQUITY
Retained Earnings -$7.602M
YoY Change 12.15%
Common Stock $60.86K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.001M
YoY Change
Total Liabilities & Shareholders Equity $535.6K
YoY Change -59.89%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$114.6K
YoY Change -4.24%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities -$105.7K
YoY Change 11.48%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -105.7K
Cash From Investing Activities 0.000
Cash From Financing Activities 0.000
Net Change In Cash -105.7K
YoY Change 11.48%
FREE CASH FLOW
Cash From Operating Activities -$105.7K
Capital Expenditures $0.00
Free Cash Flow -$105.7K
YoY Change 11.48%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-08429
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
91-1031015
dei Entity Address City Or Town
EntityAddressCityOrTown
Boise
dei Entity Address State Or Province
EntityAddressStateOrProvince
ID
CY2023Q4 us-gaap Land
Land
332509 usd
CY2023Q4 us-gaap Assets
Assets
986388 usd
CY2024Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
37180 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1285512 usd
CY2023Q4 thmg Accrued Reclamation Costs Non Current
AccruedReclamationCostsNonCurrent
81250 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7168608 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-1000839 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-567005 usd
CY2024Q3 us-gaap Minority Interest
MinorityInterest
169639 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
169639 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-831200 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-397366 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
535562 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
986388 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
20921 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-414098 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-29117 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-473189 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-7494 usd
CY2024Q3 us-gaap Accrued Reclamation Costs Current
AccruedReclamationCostsCurrent
81250 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
41625 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-115226 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-103409 usd
CY2024Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 usd
CY2023Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-16688 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60855579 shares
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
30732 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
19465 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
29244 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-5433 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-463189 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
419861 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-397366 usd
CY2024Q3 thmg Property Plant And Equipment Net Excluding Land
PropertyPlantAndEquipmentNetExcludingLand
0 usd
dei Entity Registrant Name
EntityRegistrantName
THUNDER MOUNTAIN GOLD, INC.
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
332509 usd
CY2024Q3 us-gaap Assets
Assets
535562 usd
CY2024Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
24200 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1870 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4775000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.09
dei Amendment Flag
AmendmentFlag
false
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
24200 usd
us-gaap Depreciation
Depreciation
0 usd
thmg Unpatented Claims Lease Payments
UnpatentedClaimsLeasePayments
9724 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
95544 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
95544 usd
CY2024Q3 us-gaap Land
Land
332509 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
332509 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
us-gaap Net Income Loss
NetIncomeLoss
-433834 usd
dei City Area Code
CityAreaCode
208
dei Local Phone Number
LocalPhoneNumber
658-1037
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
332509 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6835 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21629 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7022 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
18612 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3532 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Other Income
OtherIncome
595 usd
CY2023Q3 us-gaap Other Income
OtherIncome
396 usd
us-gaap Depreciation
Depreciation
552 usd
thmg Proceeds From Deposit On Land Purchase
ProceedsFromDepositOnLandPurchase
-10000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
170628 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
682718 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
141511 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
209529 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
38701 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-831200 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
95544 usd
CY2023Q4 us-gaap Land
Land
332509 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3450000 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.09
CY2024Q3 us-gaap Share Price
SharePrice
0.042
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
38701 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.07 pure
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1734 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y
dei Entity Central Index Key
EntityCentralIndexKey
0000711034
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Entity Address Address Line1
EntityAddressAddressLine1
11770 W President Dr. STE F
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
141511 usd
CY2024Q3 us-gaap Exploration Expense
ExplorationExpense
40164 usd
CY2023Q3 us-gaap Exploration Expense
ExplorationExpense
12753 usd
CY2024Q3 us-gaap Legal Fees
LegalFees
13861 usd
CY2023Q3 us-gaap Legal Fees
LegalFees
11987 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
61201 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
78669 usd
CY2023Q3 us-gaap Depreciation Nonproduction
DepreciationNonproduction
0 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
115226 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
595 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-16292 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-114631 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-119701 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60855579 shares
us-gaap Net Income Loss
NetIncomeLoss
-427355 usd
us-gaap Net Income Loss
NetIncomeLoss
-427355 usd
us-gaap Net Income Loss
NetIncomeLoss
-433834 usd
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
60855579 shares
CY2023Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
1104625 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 thmg Property Plant And Equipment Net Excluding Land
PropertyPlantAndEquipmentNetExcludingLand
0 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P1Y6M14D
us-gaap Operating Lease Expense
OperatingLeaseExpense
15938 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
39050 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
136685 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
136685 usd
thmg Noncash Lease Expense
NoncashLeaseExpense
-328 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
384981 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
0 usd
CY2024Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
384981 usd
CY2024Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
518223 cad
CY2024Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.0594
CY2024Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.0801
CY2024Q1 us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
42855 usd
CY2023Q4 us-gaap Area Of Land
AreaOfLand
56 acre
CY2023Q4 us-gaap Payments To Acquire Land
PaymentsToAcquireLand
52176 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
332509 usd
CY2023Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
1104625 usd
CY2024Q3 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
1104625 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
1325000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
1325000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue
0.09
CY2024Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
5020 usd
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
83713-8986
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q4 thmg Investment At Fair Value
InvestmentAtFairValue
427836 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
54707 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
33786 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
196218 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
632250 usd
CY2024Q3 us-gaap Land
Land
332509 usd
CY2024Q3 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
1104625 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1298972 usd
CY2024Q3 thmg Accrued Reclamation Costs Non Current
AccruedReclamationCostsNonCurrent
81250 usd
CY2024Q3 us-gaap Liabilities
Liabilities
1366762 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1383754 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60855579 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60855579 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60855579 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60855579 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
60856 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
60856 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6564947 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6564947 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7602442 usd
us-gaap Exploration Expense
ExplorationExpense
82524 usd
us-gaap Exploration Expense
ExplorationExpense
55760 usd
us-gaap Legal Fees
LegalFees
71596 usd
us-gaap Legal Fees
LegalFees
88950 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
238572 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
314545 usd
CY2024Q3 us-gaap Depreciation Nonproduction
DepreciationNonproduction
0 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
0 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
552 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
103409 usd
us-gaap Operating Expenses
OperatingExpenses
392692 usd
us-gaap Operating Expenses
OperatingExpenses
459807 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-392692 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-459807 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
30732 usd
us-gaap Other Income
OtherIncome
1713 usd
us-gaap Other Income
OtherIncome
1720 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-41142 usd
us-gaap Profit Loss
ProfitLoss
-433834 usd
us-gaap Profit Loss
ProfitLoss
-427355 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-114631 usd
us-gaap Net Income Loss
NetIncomeLoss
-427355 usd
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60855579 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60855579 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60855579 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60855579 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60855579 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60855579 shares
thmg Noncash Lease Expense
NoncashLeaseExpense
0 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-42855 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0 usd
thmg Accrued Legal Fees
AccruedLegalFees
0 usd
thmg Accrued Legal Fees
AccruedLegalFees
-10000 usd
thmg Proceeds From Deposit On Land Purchase
ProceedsFromDepositOnLandPurchase
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
112207 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-119701 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-7494 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-716569 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-114631 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-831200 usd
thmg Advanced Payment On Royalties
AdvancedPaymentOnRoyalties
5000000 usd
thmg Advanced Payment On Royalties
AdvancedPaymentOnRoyalties
5000000 usd
thmg Advance Net Returns On Royalty
AdvanceNetReturnsOnRoyalty
5000 usd
CY2024Q1 thmg Advanced Payment On Royalties
AdvancedPaymentOnRoyalties
5000 usd
CY2024Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
6636000 shares
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
95544 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
14795 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
170628 usd
CY2024Q3 thmg Investment At Fair Value
InvestmentAtFairValue
0 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
11700 shares
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
11700 shares
CY2024Q3 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
0 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
0 usd
us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
42855 usd
us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
32452 usd
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-119701 usd
us-gaap Net Income Loss
NetIncomeLoss
-433834 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
384981 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7602442 usd
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="text-decoration:underline">Accounting Estimates</span></span></span></p> <p style="margin-left:18pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The more significant areas requiring the use of management estimates and assumptions include the carrying value of properties and mineral interests, environmental remediation liabilities, deferred tax assets, and stock-based compensation. Management's estimates and assumptions are based on historical experience and other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates.</span></span></p> </div>
CY2023Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P24M

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001062993-24-019025-index-headers.html Edgar Link pending
0001062993-24-019025-index.html Edgar Link pending
0001062993-24-019025.txt Edgar Link pending
0001062993-24-019025-xbrl.zip Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
exhibit32-2.htm Edgar Link pending
exhibit95.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
form10qxz001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
form10q_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
thmg-20240930.xsd Edgar Link pending
thmg-20240930_cal.xml Edgar Link unprocessable
thmg-20240930_def.xml Edgar Link unprocessable
thmg-20240930_lab.xml Edgar Link unprocessable
thmg-20240930_pre.xml Edgar Link unprocessable